These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19500577)

  • 1. Effects of prodynorphin deletion on striatal dopamine in mice during normal aging and in response to MPTP.
    Nguyen XV; Liu M; Kim HC; Bing G
    Exp Neurol; 2009 Sep; 219(1):228-38. PubMed ID: 19500577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
    Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
    J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
    Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Przybyłkowski A; Gromadzka G; Członkowska A; Członkowski A
    Neuroimmunomodulation; 2007; 14(5):255-65. PubMed ID: 18196934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(-)-deprenyl.
    Quinn LP; Perren MJ; Brackenborough KT; Woodhams PL; Vidgeon-Hart M; Chapman H; Pangalos MN; Upton N; Virley DJ
    J Neurosci Methods; 2007 Aug; 164(1):43-9. PubMed ID: 17498809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
    McArthur S; Murray HE; Dhankot A; Dexter DT; Gillies GE
    J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
    Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
    J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S; Morissette M; Morin N; Di Paolo T
    J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action.
    Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K
    Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
    Guigoni C; Dovero S; Aubert I; Li Q; Bioulac BH; Bloch B; Gurevich EV; Gross CE; Bezard E
    Eur J Neurosci; 2005 Jul; 22(1):283-7. PubMed ID: 16029219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular distribution of interleukin-1alpha-immunoreactivity after MPTP intoxication in mice.
    Hébert G; Mingam R; Arsaut J; Dantzer R; Demotes-Mainard J
    Brain Res Mol Brain Res; 2005 Aug; 138(2):156-63. PubMed ID: 15922486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
    Andersson DR; Nissbrandt H; Bergquist F
    Eur J Neurosci; 2006 Jul; 24(2):617-24. PubMed ID: 16903863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ethanol intake in prodynorphin knockout mice is associated to changes in opioid receptor function and dopamine transmission.
    Femenía T; Manzanares J
    Addict Biol; 2012 Mar; 17(2):322-37. PubMed ID: 21966993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
    San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
    Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.